3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
12
Phase 2
10
Phase 3
4
Phase 1
3
Phase 4
2
Phase 2/3
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
19
INDUSTRY
15
OTHER_GOV
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
4
Neoplasms
3
Rectal Neoplasms
2
Prostatic Neoplasms
2
Polycystic Ovary Syndrome
2
Leukemia, Myeloid, Acute
2
Carcinoma, Hepatocellular
2
Weight Loss
1
Warts
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oesophagogastric Cancer
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukopenia
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Insulin Resistance
1
Infertility
1
Immunotherapy Gastrict Cancer
1
Hydatidiform Mole
1
Glioma
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
OTHER_GOV
×
Recurrence
×
Clear all
NCT07502118
2026-03-30
NexCAR19
Health Institutes of Turkey
Phase 2/3
Recruiting
40 enrolled